Heads Up! Big News on Stem Cells & Covid This Weekend.

Gentlemen Start Your Research Engines! Be Fast and Be Early. We Could be Looking at a "Beam Me Up Scotty" Type Vector...
Biotech Stock Review

Video: Okay, You Tested Positive for Corona, Now What?

https://youtu.be/vN30emwcNS4 Professor Roger Seheult,...
dexamethasone, Hepion

Remember President Trump Taking Dexamethasone? Hepion’s (HEPA) CRV431 demonstrated reduced lung inflammation and damage...

Hepion (HEPA) Announces FDA Clearance of IND Application for CRV431 for COVID-19
Aphex

Aphex BioCleanse Systems (SNST) Signs European Supply and Private Label Agreement for DermAphex® and...

PITTSFORD, N.Y. , Dec. 16, 2020 /PRNewswire/ -- Aphex BioCleanse Systems, Inc. (OTCPK: SNST) ("Aphex" or "the Company") , a sanitization solutions company focused on the development and distribution...
Dr. Marc Hellerstein

Some Scientists Aren’t So Sure A Coronavirus Vaccine Will Come To The Rescue.

Pandemic-weary residents everywhere are holding their breath for the first coronavirus vaccines to be approved by federal regulators. The shots, currently being...
Cyclophilin, Biotech Stock Review

Adding Hepion Pharma (HEPA) $1.73 to Watch List.

Adding Hepion Pharma ($1.73) to Watch List. Oh My. What Did We Find Here? Oh my…and Oh boy....
Internet Stock Review

Newsletter: Institutional Analyst. And Yes, We Have Another Double.

1. Dalrada (DFCO) $0.19. And Yes, We Have Another Double!2. Dyadic (DYAI) $6.40. We're Up 392%, Video Presentation.3....

Committed to Win. C-1 and Dyadic’s (DYAI) Drive to Make Vaccines Affordable Worldwide.

Dyadic International, Inc. (NASDAQ: DYAI) – We are a global biotechnology company focused on further improving and leveraging the patented and proprietary...
Dalrada

Dalrada (DFCO) Finally Pops. Up 59% Today.

Up 59% today on news and with 4 million shares trading and counting! LIVE QUOTE

Latest article

Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...

GeoVax (GOVX) Launches Vaccine Manufacturing System.

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System Manufacturing Process for Phase 3 and Commercial Production...

Experts From Harvard, Scripps Research Institute, the University Hospital Zürich, and the Former Chief...

Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody...